Bo Xu

2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Predicting Survival in Pulmonary Arterial Hypertension

Long-Term Comparison of Drug-Eluting Stents and Coronary Artery Bypass Grafting for Multivessel Coronary Revascularization

Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial

Roles of microRNA-124a and microRNA-30d in breast cancer patients with type 2 diabetes mellitus

Survival of Chinese Patients With Pulmonary Arterial Hypertension in the Modern Treatment Era

Physical and mechanical properties of PLA, and their functions in widespread applications — A comprehensive review

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Prognostic Value of the SYNTAX Score in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

Definitions and Diagnosis of Pulmonary Hypertension

A global view of pulmonary hypertension

Design of the REVEAL Registry for US Patients With Pulmonary Arterial Hypertension

Exercise Standards for Testing and Training

The Changing Picture of Patients With Pulmonary Arterial Hypertension in the United States

The impact of increased age on outcome from a strategy of early invasive management and revascularisation in patients with acute coronary syndromes: retrospective analysis study from the ACACIA registry

Changes in causes of death in systemic sclerosis, 1972–2002

Antiplatelet Therapy After Implantation of Bioresorbable Vascular Scaffolds

Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association

Pulmonary arterial hypertension in Saudi Arabia: Patients′ clinical and physiological characteristics and hemodynamic parameters. A single center experience

The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm

Pulmonary Arterial Hypertension

Drug-eluting stents versus coronary artery bypass grafting for the treatment of coronary artery disease: A meta-analysis of randomized and nonrandomized studies

Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial

Updated Clinical Classification of Pulmonary Hypertension

A Randomized Clinical Study Comparing Double Kissing Crush With Provisional Stenting for Treatment of Coronary Bifurcation Lesions

Acute Myocardial Infarction

Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension

Cardiopulmonary exercise testing in the assessment of pulmonary hypertension

Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension in the Southern Hemisphere

Case Volume and Outcomes After TAVR With Balloon-Expandable Prostheses

Delay in Recognition of Pulmonary Arterial Hypertension

The increase in pulmonary arterial pressure caused by hypoxia depends on iron status

Survival in Schistosomiasis-Associated Pulmonary Arterial Hypertension

An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL Registry

Coronary Stents

Changing Demographics, Epidemiology, and Survival of Incident Pulmonary Arterial Hypertension

2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association

Does body mass index truly affect mortality and cardiovascular outcomes in patients after coronary revascularization with percutaneous coronary intervention or coronary artery bypass graft? A systematic review and network meta‐analysis

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease

Pulmonary Arterial Hypertension

Effects of Mobile Text Messaging on Glycemic Control in Patients With Coronary Heart Disease and Diabetes Mellitus

Diagnostic value of the blood monocyte–lymphocyte ratio in knee osteoarthritis

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

Impact of Smoking Status on Stroke Recurrence

Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease

Saudi experience in the management of pulmonary arterial hypertension; the outcome of PAH therapy with the exclusion of chronic parenteral prostacyclin

The Versatile Role of microRNA-30a in Human Cancer

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

Comparative Efficacy and Safety of Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stents

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Irritable bowel syndrome is associated with novel inflammatory markers derived from hemogram parameters

Design of the REVEAL Registry for US Patients With Pulmonary Arterial Hypertension

The china patient‐centered evaluative assessment of cardiac events (PEACE) prospective study of percutaneous coronary intervention: Study design

Immediate and long-term outcomes of drug-eluting stent implantation for unprotected left main coronary artery disease: Comparison with bare-metal stent implantation

Effect of Lifestyle Changes after Percutaneous Coronary Intervention on Revascularization

Impact of Body Mass Index on the Clinical Outcomes after Percutaneous Coronary Intervention in Patients ≥75 Years Old

Comparison Between the NERS (New Risk Stratification) Score and the SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) Score in Outcome Prediction for Unprotected Left Main Stenting

Registry and Survival Study in Chinese Patients With Idiopathic and Familial Pulmonary Arterial Hypertension

Safety and Efficacy of Biodegradable Polymer-Coated Sirolimus-Eluting Stents in “Real-World” Practice

Relationship of Glycated Hemoglobin Levels with Myocardial Injury following Elective Percutaneous Coronary Intervention in Patients with Type 2 Diabetes Mellitus

Effect of the CYP2C19*2 and *3 genotypes, ABCB1 C3435T and PON1 Q192R alleles on the pharmacodynamics and adverse clinical events of clopidogrel in Chinese people after percutaneous coronary intervention

Bioresorbable Vascular Scaffolds Versus Metallic Stents in Patients With Coronary Artery Disease

Comparison of Drug-Eluting Stents and Coronary Artery Bypass Surgery for the Treatment of Multivessel Coronary Disease

Bivalirudin vs Heparin With or Without Tirofiban During Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction

Clinical utility of multi‐detector cardiac computed tomography in structural heart interventions

Predictive value of neutrophil to lymphocyte ratio in long‐term outcomes of left main and/or three‐vessel disease in patients with acute myocardial infarction